• High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
  • High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2

High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2

Powder: Yes
Customized: Non-Customized
Certification: GMP, HSE, ISO 9001, USP, BP
Suitable for: Adult
State: Powder/Liquid
Purity: >99%
Samples:
US$ 50/gram 1 gram(Min.Order)
| Request Sample
Customization:

Contact Supplier

Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5

Basic Info.

Model NO.
TGY022019090902
Product Name
Afatinib
Specificcation
99%
Grade
Pharmaceuticals Grade
Storage
Cool Dry Place
Shipping Time
Within 3-7 Working Days
Appearance
White Powder
CAS
439081-18-2
Transport Package
Foil Bag, Box, Drum
Specification
99% min
Trademark
TGY
Origin
China
HS Code
300440906
Production Capacity
1500kg/Month

Product Description



High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
Product name: Afatinib (BIBW 2992);Gilotrif
Synonyms: BIBW 2992;N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]-4-(dimethylamino)-2-butenamide;Tovok;Tovok, BIBW 2992;BIBW2992 Afatinib;Afatinib (BIBW 2992);ToMtovok;(S,E)-N-(4-(3-chloro-4-fluorophenylaMino)-7-(tetrahydrofuran-3-yloxy)quinazolin-6-yl)-4-(diMethylaMino)but-2-enaMide
CAS: 439081-18-2
MF: C24H25ClFN5O3
MW: 485.944
Purity: 99.5% min 
Appearance: White or Nearly White Crystalline Powder
MOQ: 10G
Specifications: Pharmaceutical Grade
Deliver time: About 5 days
Deliver methods: TNT,EMS,HKEMS,DHL,ect.(door to door)

High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
1.Afatinib is pronounced aff-a-tin-ib. It has the brand name Giotrif (jee-oh-triff). It is a type of biological therapy called a tyrosine kinase inhibitor (TKI). It is a treatment for non small cell lung cancer that has spread outside the lung or to other parts of the body.

2.It has received regulatory approval for use as a treatment for non-small cell lung cancer,although there is emerging evidence to support its use in other cancers such as breast cancer.

3. How afatinib works:

This type of drug works by blocking particular proteins on cancer cells that encourage the cancer to grow. Afatinib blocks proteins called epidermal receptors (EGFR). Cancers that have these receptors are called EGFR positive.

Between 10 and 15 people out of every 100 with non small cell lung cancer (10 to 15%) have EGFR positive cancer. Doctors check your cancer cells to see if they have the receptors before you have this treatment.

Afatinib may shrink the cancer or stop it growing for a time

4. Uses and fuction:

Afatinib is used to treat a certain type of lung cancer (non-small cell lung cancer) that has spread to other parts of the body. It belongs to a class of drugs known as kinase inhibitors. It works by slowing or stopping the growth of cancer cells. It binds to a certain protein (epidermal  receptor-EGFR) in some tumors.

5. Mechanism of action:

Like lapatinib and neratinib, afatinib is a protein kinase inhibitor that also irreversibly inhibits human epidermal receptor 2 (Her2) and epidermal  receptor (EGFR) kinases. Afatinib is not only active against EGFR mutations targeted by first generation tyrosine-kinase inhibitors (TKIs) likeerlotinib or gefitinib, but also against mutations such as T790M which are not sensitive to these standard therapies.Because of its additional activity against Her2, it is being investigated for breast cancer as well as other EGFR and Her2 driven cancers.

 COA:

 

Item Requirements Test Results
Description Off-white powder Off-white powder
Identification HPLC ,NMR Complies
Residue on Ignition ≤0.10% 0.05%
Loss on Drying ≤0.50% 0.15%
Heavy Metal ≤20ppm <20ppm
Purity(HPLC) ≥99.0% 99.99%
Conclusion It complies with EnterpriseStandard

 


High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2

High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
High Purity 99% Cancer Treatment Afatinib CAS 439081-18-2
 

Send your message to this supplier

*From:
*To:
avatar Miss Rebecca Lee
*Message:

Enter between 20 to 4,000 characters.

This is not what you are looking for? Post a Sourcing Request Now

You Might Also Like

Contact Supplier

Diamond Member Since 2019

Suppliers with verified business licenses

Rating: 4.9/5
Terms of Payment
LC, T/T, D/P, PayPal, Western Union, Small-amount payment
International Commercial Terms(Incoterms)
FOB, CFR, CIF, DAT, FAS, DDP, DAP, CIP, CPT, FCA, EXW, Others